Rchr
J-GLOBAL ID:200901006212212519   Update date: Aug. 04, 2024

Kazunori Kato

カトウ カズノリ | Kazunori Kato
Affiliation and department:
Job title: Associate professor
Other affiliations (1):
Research field  (7): Environmental and pharmaceutical development resources ,  Nutrition and health science ,  Pharmaceuticals - chemistry and drug development ,  Immunology ,  Other ,  Allergies and connective tissue disease ,  Hematology and oncology
Research keywords  (18): AI診断 ,  免疫機能測定法 ,  Phytochemicals ,  Bリンパ球性白血病 ,  細胞間接着分子 ,  抗体 ,  T細胞刺激補助分子 ,  自己免疫性疾患 ,  癌幹細胞 ,  エクソソーム ,  腫瘍マーカー ,  熱中症 ,  病態検査・診断 ,  バイオマーカー ,  リウマチ性血管炎 ,  生体医工学 ,  創薬科学 ,  遺伝子治療 腫瘍免疫学
Research theme for competitive and other funds  (25):
  • 2022 - 2025 Development of radio-theranostics drugs against cancers using anti-EphA2 antibody
  • 2021 - 2024 Establishment of a new preventive strategy based on the interaction of NK cells and prostate cancer stem cells
  • 2019 - 2022 Practical research for biomarkers predicting tumorigenesis in polymyositis and dermatomyositis
  • 2016 - 2019 Role of contraction-dependent myokines on the immune system
  • 2014 - 2018 Preparation of microRNA from saliva and detection of cancer and prediction of drug sensitivity using saliva
Show all
Papers (71):
  • 岩澤 卓弥, 山内 卓, 福永 哲, 折田 創, 加藤 和則. 胃癌における免疫抑制調節因子および治療標的としてのMDSCs(A new subset of granulocytic MDSCs as immunosuppressive regulators and therapeutic targets in gastric cancer). 日本癌学会総会記事. 2022. 81回. J-2059
  • 村越 真紀, 岩澤 卓弥, 合田 朋仁, 鈴木 祐介, 加藤 和則. 慢性腎臓病患者における血中EphA2濃度と尿蛋白量、推算糸球体濾過量との関連性. 日本腎臓学会誌. 2022. 64. 3. 277-277
  • Taiga Seki, Yui Shimizu, Kyota Ishii, Yuzuki Takahama, Kazunori Kato, Tomohiro Yano. Nk cells can preferentially target prostate cancer stem-like cells via the trail/dr5 signaling pathway. Biomolecules. 2021. 11. 11
  • Kouki Okita, Kazuki Imai, Kazunori Kato, Reiko Sugiura, Yuichi Endo, Kazue Masuko, Yoshihisa Tomioka, Takashi Masuko. Altered binding avidities and improved growth inhibitory effects of novel anti-HER3 mAb against human cancers in the presence of HER1-or HER2-targeted drugs. Biochemical and Biophysical Research Communications. 2021. 576. 59-65
  • Eri Watanabe, Kazunori Kato, Takahisa Gono, Emiko Chiba, Chihiro Terai, Shigeru Kotake. Serum levels of galectin-3 in idiopathic inflammatory myopathies: a potential biomarker of disease activity. Rheumatology (Oxford, England). 2021. 60. 1. 322-332
more...
MISC (212):
Patents (1):
  • 熱中症の予防、軽減及び/又は治療のための組成物
Education (3):
  • 1987 - 1991 Tohoku University Graduate School of Pharmaceutical Sciences
  • 1985 - 1987 Tohoku University Graduate School of Pharmaceutical Sciences
  • 1981 - 1985 Tohoku University Faculty of Pharmaceutical Sciences
Professional career (2):
  • Ph.D. (Tohoku University, Graduate School of Pharmaceutical Sciences)
  • Master of Pharmacy (Tohoku University, Graduate School of Pharmaceutical Sciences)
Work history (8):
  • 2023/04 - 現在 Toyo University Faculty of Health and Sports Science Professor
  • 2011/04 - 現在 Toyo University Faculty of Science and Engineering Professor
  • 2011/03 - 現在 Juntendo University Graduate School of Medicine
  • 2009/05 - 2011/03 Juntendo University Graduate School of Medicine Associate Professor
  • 2002/04 - 2009/03 Sapporo Medical University Research Institute for Frontier Medicine Associate Professor
Show all
Association Membership(s) (6):
日本癌学会 ,  日本免疫学会 ,  アメリカ癌学会 ,  日本食品免疫学会 ,  日本生化学会 ,  日本がん免疫学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page